Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 03. 29.
 2007³â 1Â÷ ÀÌÁ¾Àå±â(ÆǸ·,ÆǸ·µµ°ü) ¿¬±¸¹ßǥȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2007.04.18. 15:06:29   Á¶È¸: 4508
2007³â 4¿ù 17ÀÏ ¿ÀÈÄ 6½Ã-9½Ã Grand Intercontinental Hotel ¿¡¼­
2007³âµµ Á¦1Â÷ ÀÌÁ¾Àå±â ÆǸ·, ÆǸ·µµ°ü¿¬±¸ ¹ßǥȸ¸¦ °³ÃÖÇÏ¿´´Ù.
¹ßÇ¥ ¿¬Á¦;
 
1. Introduction of xenograft tissue pressrvation : ±è¿ëÁø
2. Manufacturing process & LinX Treatment of SJM  THV ;
    Mark Bullivant, Director of Marketing, Cardiac Surgery,
    ST Jude Medical International  Division
3. Detoxification of GA-fixed pericardium & Various Methods
     for in vitro material assessment " ( calcium analysis,
     thermal denaturation temperture ,amino acid analysis,
     lipid content analysis ) ; ÀÌö
4. Role of Heparin in Bioprosthesis ; ¾çÁöÇõ
5. µÅÁöÀÇ ÆǸ·¿¡¼­ galactosidase ¸¦ ÀÌ¿ëÇÑ  a-Gal epitope
      Á¦°Å ; ¹Ú¼º½Ä
6. Sterilization effect of various reagents during fixation
      ; ÃÖâÈÞ
7. Plans for lage animal valve implantation experiments for
    systemic & pulmonic position ; ±è¿õÇÑ
8. Adjourn
 
 
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 03. 29.  Àüü±Û: 211  ¹æ¹®¼ö: 1016502
62 Áß±¹ ÇϾóºó ¾Æµ¿º´¿ø½ÉÀå¼ö¼ú °ü¸®ÀÚ2008.04.13.4148
61 Á¦ 16Â÷ ¾Æ½Ã¾Æ½ÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ ±è¿ëÁø2008.03.17.4230
60 Áß±¹ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.11.30.4542
59 Áß±¹ »êµ¿¼º Áö³­ õºÒ»êº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.11.19.5335
58 ÇϾóºó¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.10.29.5678
57 ÀÌÁ¾ ÆǸ·°³¹ß ¿¬±¸¼¼¹Ì³ª °ü¸®ÀÚ2007.10.29.4753
56 Á¦ 10Â÷ ¼Ò¾Æ½ÉÀå ½ÉÆ÷Áö¿ò °ü¸®ÀÚ2007.08.31.4390
55 Áß±¹ Áß°æ½Ã Á߻꺴¿ø½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.08.16.4799
54 Áß±¹ ÇϾóºó¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.06.25.4805
53 Áß±¹ ¿¬±æ º¹Áöº´¿ø½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.06.25.4756
RELOAD WRITE
 1 ¢¸ [11] [12] [13] [14] 15 [16] [17] [18] [19] [20]  ¢º 22